Influence of passive permeability on apparent P-glycoprotein kinetics

被引:106
作者
Lentz, KA
Polli, JW
Wring, SA
Humphreys, JE
Polli, JE [1 ]
机构
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[2] Glaxo Wellcome Inc, Div Bioanal & Drug Metab, Res Triangle Pk, NC 27709 USA
关键词
P-glycoprotein; passive permeability;
D O I
10.1023/A:1007692622216
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose, The objectives of this work were to evaluate the importance of moderate passive permeability on apparent P-glycoprotein (P-gp) kinetics, and demonstrate: that inspection of basolateral to apical and apical to basolateral (BL-AP/AP-BL) permeability ratios may result in a compound being overlooked as a P-gp substrate and inhibitor of another drug's transport via P-gp inhibition. Methods, The permeability ratios of nicardipine, vinblastine. cimetidine, and ranitidine were determined across Caco-2 monolayers that express P-gp, in the presence and absence of the specific P-gp inhibitor, GF120918. In addition, the permeability ratio of vinblastine was studied after pretreatment of Caco-2 monolayers with nicardipine. ranitidine. or cimetidine. Similar studies were repeated with hMDR1-MDCK monolayers. Results. The permeability ratios for cimetidine and vinblastine were >2. The permeability ratios for nicardipine and ranitidine were close to unity, and were not affected by the addition of GF120918. Based solely on ratios, only compounds with moderate transcellular permeability (vinblastine and cimetidine) would be identified as P-gp substrates. Although the permeability ratios appeared to be unity for nicardipine and ranitidine. both compounds affected the permeability of vinblastine. and were identified as substrates and inhibitors of P-gp. Studies performed in hMDR1-MDCK cells confirmed these experimental results. Data were explained in the context of a kinetic model, where passive permeability and P-gp efflux contribute to overall drug transport. Conclusions. Moderate passive permeability was necessary for P-gp to reduce the AP-BL drug permeability. Inspection of the permeability ratio alter directional transport studies did not effectively identify P-gp substrates that affected the P-gp kinetics of vinblastine. Because of the role of passive permeability, drug interaction studies with known P-gp substrates. rather than directional permeability studies, are needed to elucidate a more complete understanding of P-gp kinetics.
引用
收藏
页码:1456 / 1460
页数:5
相关论文
共 17 条
[1]   UNIDIRECTIONAL FLUXES OF RHODAMINE-123 IN MULTIDRUG-RESISTANT CELLS - EVIDENCE AGAINST DIRECT DRUG EXTRUSION FROM THE PLASMA-MEMBRANE [J].
ALTENBERG, GA ;
VANOYE, CG ;
HORTON, JK ;
REUSS, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4654-4657
[2]   Role of P-glycoprotein-mediated secretion in absorptive drug permeability:: An approach using passive membrane permeability and affinity to P-glycoprotein [J].
Doppenschmitt, S ;
Spahn-Langguth, H ;
Regårdh, CG ;
Langguth, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (10) :1067-1072
[3]   Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1 [J].
Evers, R ;
Cnubben, NHP ;
Wijnholds, J ;
van Deemter, L ;
van Bladeren, PJ ;
Borst, P .
FEBS LETTERS, 1997, 419 (01) :112-116
[4]   Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Hurwitz, CD ;
Assaraf, YG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 248 (01) :104-112
[5]   The role of passive transbilayer drug movement in multidrug resistance and its modulation [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12897-12902
[6]   BIOPHYSICAL MODEL OF PASSIVE AND POLARIZED ACTIVE-TRANSPORT PROCESSES IN CACO-5 CELLS - APPROACHES TO UNCOUPLING APICAL AND BASOLATERAL MEMBRANE EVENTS IN THE INTACT CELL [J].
HO, NFH ;
BURTON, PS ;
CONRADI, RA ;
BARSUHN, CL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (01) :21-27
[7]   DRUG ABSORPTION LIMITED BY P-GLYCOPROTEIN-MEDIATED SECRETORY DRUG TRANSPORT IN HUMAN INTESTINAL EPITHELIAL CACO-2 CELL-LAYERS [J].
HUNTER, J ;
HIRST, BH ;
SIMMONS, NL .
PHARMACEUTICAL RESEARCH, 1993, 10 (05) :743-749
[8]   MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening [J].
Irvine, JD ;
Takahashi, L ;
Lockhart, K ;
Cheong, J ;
Tolan, JW ;
Selick, HE ;
Grove, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) :28-33
[9]   Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption - Theoretical approach [J].
Ito, K ;
Kusuhara, H ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 1999, 16 (02) :225-231
[10]   Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells [J].
Ito, S ;
Woodland, C ;
Sarkadi, B ;
Hockmann, G ;
Walker, SE ;
Koren, G .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (01) :F84-F96